ApcinteX logo

ApcinteX Ltd.

ApcinteX develops and markets anticoagulant APC pathway to treat haemophilia.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.apcintex.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
25 Great Pulteney Street, W1F 9LT
London
United Kingdom
Email
Contact Number
+44 7540 151981

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/apcintex-limited” connections=”true” suffix=””]